- Home
- CYBN vs SGC Comparison
CYBN vs SGC Comparison
Compare CYBN & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- SGC
- Stock Information
- Founded
- CYBN 2019
- SGC 1920
- Country
- CYBN Canada
- SGC United States
- Employees
- CYBN N/A
- SGC N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- SGC Apparel
- Sector
- CYBN Health Care
- SGC Consumer Discretionary
- Exchange
- CYBN Nasdaq
- SGC Nasdaq
- Market Cap
- CYBN 178.7M
- SGC 155.7M
- IPO Year
- CYBN N/A
- SGC N/A
- Fundamental
- Price
- CYBN $7.54
- SGC $9.55
- Analyst Decision
- CYBN Strong Buy
- SGC Strong Buy
- Analyst Count
- CYBN 4
- SGC 3
- Target Price
- CYBN $85.00
- SGC $17.00
- AVG Volume (30 Days)
- CYBN 412.3K
- SGC 39.8K
- Earning Date
- CYBN 08-12-2025
- SGC 08-05-2025
- Dividend Yield
- CYBN N/A
- SGC 5.86%
- EPS Growth
- CYBN N/A
- SGC N/A
- EPS
- CYBN N/A
- SGC 0.45
- Revenue
- CYBN N/A
- SGC $563,931,000.00
- Revenue This Year
- CYBN N/A
- SGC N/A
- Revenue Next Year
- CYBN N/A
- SGC $4.31
- P/E Ratio
- CYBN N/A
- SGC $21.26
- Revenue Growth
- CYBN N/A
- SGC 2.28
- 52 Week Low
- CYBN $4.81
- SGC $9.11
- 52 Week High
- CYBN $13.88
- SGC $20.15
- Technical
- Relative Strength Index (RSI)
- CYBN 46.24
- SGC 32.67
- Support Level
- CYBN $7.26
- SGC $10.46
- Resistance Level
- CYBN $7.81
- SGC $11.03
- Average True Range (ATR)
- CYBN 0.45
- SGC 0.44
- MACD
- CYBN -0.04
- SGC -0.18
- Stochastic Oscillator
- CYBN 17.72
- SGC 10.96
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.